These findings reveal that metabolism, and specifically CPT1 lipid metabolism plays a central role in the SOD1 G93A mouse model and shows that CPT1 might be a therapeutic target in ALS. The gene discussed is CPT1A; the disease is amyotrophic lateral sclerosis.